Key facts
- This page summarizes Jennifer Stevens's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 20 Mar 2026, 16:25.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Additional SEC filing notes
Footnote F1
Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person.